TNFSF10 and coronary artery disorder: In agreement with these preclinical observations on the relationship between TRAIL and cardiovascular disease, some clinical studies found that in patients with coronary artery disease [7]–[9] TRAIL levels tend to be lower and inversely correlated with biomarkers of myocardial damage and with C-reactive protein [8], a strong predictor of future cardiovascular events [10].